You are here

  • Home
  • Archive
  • Volume 25, Issue 5
  • Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study

Article info

Article menu
Download PDFPDF
Original Articles
Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study

Authors

  1. Reprint requests: Peter Dahm, M.D., Consultant, Department of Anesthesia, Sahlgrenska Hospital, Göteborg University, S-413 45 Gothenburg, Sweden.

Citation

Dahm P, Lundborg C, Janson M, et al
Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study
Regional Anesthesia & Pain Medicine 2000;25:480-487.

Publication history

  • First published September 1, 2000.
Online issue publication 
February 27, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2000 by the American Society of Regional Anesthesia and Pain Medicine